Methodological aspects of oxygen gradient ektacytometry in sickle cell disease: Effects of sample storage on outcome parameters in distinct patient subgroups
Camille Boisson(Lyon 1 Université), Philippe Connes(Université Claude Bernard Lyon 1), Romain Fort(Hospices Civils de Lyon), Élie Nader(Université Claude Bernard Lyon 1), Céline Renoux(Lyon 1 Université), Minke A.E. Rab(Utrecht University), Philippe Joly(Lyon 1 Université), Richard van Wijk(Utrecht University), Brigitte A. van Oirschot(Utrecht University), Eduard J. van Beers(Utrecht University), Émeric Stauffer(Lyon 1 Université), Vivien Sheehan(Emory University)
Cited by 15
Related Papers
The energy-less red blood cell is lost: erythrocyte enzyme abnormalities of glycolysis
|Blood|2005|366
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study
|Blood|2018|165
Safety and Efficacy of Mitapivat in Pyruvate Kinase Deficiency
|New England Journal of Medicine|2019|162
AG-348 (Mitapivat), an allosteric activator of red blood cell pyruvate kinase, increases enzymatic activity, protein stability, and ATP levels over a broad range of PKLR genotypes
|Haematologica|2020|81
Rapid and reproducible characterization of sickling during automated deoxygenation in sickle cell disease patients
|American Journal of Hematology|2019|76